Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression

<p><strong>Background:</strong> Elevated rate of aging-related biological and functional decline, termed “accelerated aging,” is reported in patients with schizophrenia (SCZ) and major depressive disorder (MDD). We used diffusion tensor imaging derived fractional anisotropy (FA) as...

Full description

Bibliographic Details
Main Authors: Kochunov, P, Glahn, D, Rowland, L, Olvera, R, Winkler, A, Yang, Y, Sampath, H, Carpenter, W, Duggirala, R, Curran, J, Blangero, J, Hong, L
Format: Journal article
Language:English
Published: Elsevier 2013
Subjects:
_version_ 1797092113267032064
author Kochunov, P
Glahn, D
Rowland, L
Olvera, R
Winkler, A
Yang, Y
Sampath, H
Carpenter, W
Duggirala, R
Curran, J
Blangero, J
Hong, L
author_facet Kochunov, P
Glahn, D
Rowland, L
Olvera, R
Winkler, A
Yang, Y
Sampath, H
Carpenter, W
Duggirala, R
Curran, J
Blangero, J
Hong, L
author_sort Kochunov, P
collection OXFORD
description <p><strong>Background:</strong> Elevated rate of aging-related biological and functional decline, termed “accelerated aging,” is reported in patients with schizophrenia (SCZ) and major depressive disorder (MDD). We used diffusion tensor imaging derived fractional anisotropy (FA) as a biomarker of aging-related decline in white matter (WM) integrity to test the hypotheses of accelerated aging in SCZ and MDD.</p> <p><strong>Methods:</strong> The SCZ cohort comprised 58 SCZ patients and 60 controls (aged 20–60 years). The MDD cohort comprised 136 MDD patients and 351 controls (aged 20–79 years). The main outcome measures were the diagnosis-by-age interaction on whole-brain-averaged WM FA values and FA values from 12 major WM tracts.</p> <p><strong>Results:</strong> Diagnosis-by-age interaction for the whole-brain average FA was significant for the SCZ (<em>p</em> = .04) but not the MDD (<em>p</em> = .80) cohort. Diagnosis-by-age interaction was nominally significant (<em>p</em> &lt; .05) for five WM tracts for SCZ and for none of the tracts in the MDD cohort. Tract-specific heterochronicity of the onset of age-related decline in SCZ demonstrated strong negative correlations with the age-of-peak myelination and the rates of age-related decline obtained from normative sample (r = −.61 and −.80, p &lt; .05, respectively). No such trends existed for MDD cohort.</p> <p><strong>Conclusions:</strong> Cerebral WM showed accelerated aging in SCZ but not in MDD, suggesting some difference in the pathophysiology underlying their WM aging changes. Tract-specific heterochronicity of WM development modulated presentation of accelerated aging in SCZ: WM tracts that matured later in life appeared more sensitive to the pathophysiology of SCZ and demonstrated more susceptibility to disorder-related accelerated decline in FA values with age. This trend was not observed in MDD cohort.</p>
first_indexed 2024-03-07T03:41:43Z
format Journal article
id oxford-uuid:be20417b-e8f0-4f11-be8e-b2cf9e1bccc3
institution University of Oxford
language English
last_indexed 2024-03-07T03:41:43Z
publishDate 2013
publisher Elsevier
record_format dspace
spelling oxford-uuid:be20417b-e8f0-4f11-be8e-b2cf9e1bccc32022-03-27T05:36:57ZTesting the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depressionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:be20417b-e8f0-4f11-be8e-b2cf9e1bccc3NeuropsychologyPsychiatryEnglishSymplectic Elements at OxfordElsevier2013Kochunov, PGlahn, DRowland, LOlvera, RWinkler, AYang, YSampath, HCarpenter, WDuggirala, RCurran, JBlangero, JHong, L<p><strong>Background:</strong> Elevated rate of aging-related biological and functional decline, termed “accelerated aging,” is reported in patients with schizophrenia (SCZ) and major depressive disorder (MDD). We used diffusion tensor imaging derived fractional anisotropy (FA) as a biomarker of aging-related decline in white matter (WM) integrity to test the hypotheses of accelerated aging in SCZ and MDD.</p> <p><strong>Methods:</strong> The SCZ cohort comprised 58 SCZ patients and 60 controls (aged 20–60 years). The MDD cohort comprised 136 MDD patients and 351 controls (aged 20–79 years). The main outcome measures were the diagnosis-by-age interaction on whole-brain-averaged WM FA values and FA values from 12 major WM tracts.</p> <p><strong>Results:</strong> Diagnosis-by-age interaction for the whole-brain average FA was significant for the SCZ (<em>p</em> = .04) but not the MDD (<em>p</em> = .80) cohort. Diagnosis-by-age interaction was nominally significant (<em>p</em> &lt; .05) for five WM tracts for SCZ and for none of the tracts in the MDD cohort. Tract-specific heterochronicity of the onset of age-related decline in SCZ demonstrated strong negative correlations with the age-of-peak myelination and the rates of age-related decline obtained from normative sample (r = −.61 and −.80, p &lt; .05, respectively). No such trends existed for MDD cohort.</p> <p><strong>Conclusions:</strong> Cerebral WM showed accelerated aging in SCZ but not in MDD, suggesting some difference in the pathophysiology underlying their WM aging changes. Tract-specific heterochronicity of WM development modulated presentation of accelerated aging in SCZ: WM tracts that matured later in life appeared more sensitive to the pathophysiology of SCZ and demonstrated more susceptibility to disorder-related accelerated decline in FA values with age. This trend was not observed in MDD cohort.</p>
spellingShingle Neuropsychology
Psychiatry
Kochunov, P
Glahn, D
Rowland, L
Olvera, R
Winkler, A
Yang, Y
Sampath, H
Carpenter, W
Duggirala, R
Curran, J
Blangero, J
Hong, L
Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression
title Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression
title_full Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression
title_fullStr Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression
title_full_unstemmed Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression
title_short Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression
title_sort testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression
topic Neuropsychology
Psychiatry
work_keys_str_mv AT kochunovp testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT glahnd testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT rowlandl testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT olverar testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT winklera testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT yangy testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT sampathh testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT carpenterw testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT duggiralar testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT curranj testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT blangeroj testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression
AT hongl testingthehypothesisofacceleratedcerebralwhitematteraginginschizophreniaandmajordepression